Yuyu Pharma Inc
KRX:000220

Watchlist Manager
Yuyu Pharma Inc Logo
Yuyu Pharma Inc
KRX:000220
Watchlist
Price: 4 600 KRW 0.11% Market Closed
Market Cap: 74.4B KRW

Yuyu Pharma Inc
Operating Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Yuyu Pharma Inc
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Yuyu Pharma Inc
KRX:000220
Operating Income
â‚©9.4B
CAGR 3-Years
115%
CAGR 5-Years
3%
CAGR 10-Years
17%
Yuhan Corp
KRX:000100
Operating Income
â‚©92B
CAGR 3-Years
39%
CAGR 5-Years
25%
CAGR 10-Years
1%
SK Biopharmaceuticals Co Ltd
KRX:326030
Operating Income
â‚©147.6B
CAGR 3-Years
178%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Operating Income
â‚©200.9B
CAGR 3-Years
10%
CAGR 5-Years
17%
CAGR 10-Years
35%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Operating Income
-â‚©1.8B
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Caregen Co Ltd
KOSDAQ:214370
Operating Income
â‚©36.4B
CAGR 3-Years
7%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
No Stocks Found

Yuyu Pharma Inc
Glance View

Market Cap
72.5B KRW
Industry
Pharmaceuticals

Yuyu Pharma, Inc. engages in the manufacture and sale of pharmaceuticals. The company is headquartered in Jecheon, Chungcheongbuk-Do. The firm produces prescription drugs such as circulatory improvement agents, antiplatelet agents, osteoporosis drugs, antiulcerants, bone metabolism ameliorants, gout preparative drugs, antidepressants, anti-diabetic agents, antitubercular agents, antihypertensive agents, angina pectoris drugs, antibiotics, hemorrhoidal and varicose preparations, topical corticosteroids and others, as well as non-prescription drugs such as vitamins and digestive agents. The company also provides healthcare supplements and quasi drugs. In addition, the Company is involved in the provision of medicines for geriatric diseases such as osteoporosis, dementia, stroke and others.

Intrinsic Value
5 504.98 KRW
Undervaluation 16%
Intrinsic Value
Price

See Also

What is Yuyu Pharma Inc's Operating Income?
Operating Income
9.4B KRW

Based on the financial report for Jun 30, 2025, Yuyu Pharma Inc's Operating Income amounts to 9.4B KRW.

What is Yuyu Pharma Inc's Operating Income growth rate?
Operating Income CAGR 10Y
17%

Over the last year, the Operating Income growth was -21%. The average annual Operating Income growth rates for Yuyu Pharma Inc have been 115% over the past three years , 3% over the past five years , and 17% over the past ten years .

Back to Top